Feedback / Questions
Kadcyla (ado-trastuzumab emtansine) - Roche
Aidixi (disitamab vedotin) - Rongchang Pharma, Seagen
trastuzumab duocarmazine (SYD985) - Byondis
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
ADCT-502 - ADC Therapeutics
http://www.ncbi.nlm.nih.gov/pubmed/35180563
Feb 19, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next